Blog Category

Financial

Biophytis announces the implementation of a reverse stock split of its ordinary shares traded on Euronext Growth

,

/

15 March 2024

Biophytis announces the drawing of the fourth tranche of ORNANE under the 2021 Atlas Contract

,

/

29 December 2023

Biophytis announces the success of its capital increase with preferential subscription rights for approximately €1.96 million

,

/

20 November 2023

Biophytis receives notice of delisting from Nasdaq and announces it will request a hearing before the Nasdaq Hearings Panel

,

/

27 October 2023

Biophytis announces the launch of a rights issue with maintenance of shareholders’ preferential subscription rights to continue the execution of its strategic roadmap

,

/

23 October 2023

Biophytis releases its half-yearly accounts as of 30 June 2023 and provides an update on its operations

,

/

27 September 2023

Biophytis Announces $3.8 Million Registered Direct Offering

,

/

19 July 2023

HALF-YEAR REPORT ON THE BIOPHYTIS LIQUIDITY CONTRACT

, , ,

/

11 July 2023

Biophytis announces receipt of Nasdaq Notice

,

/

28 April 2023

Biophytis regains compliance with NASDAQ minimum bid price requirement

,

/

19 April 2023

Biophytis announces ratio change under its American Depositary Receipt (“ADR”) program

,

/

17 March 2023

Biophytis publishes its interim financial report for the first half of 2022 and its adjusted financial results as of 31 December 2021

, , ,

/

31 January 2023